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Abstract Mantle cell lymphoma (MCL) is a rare
aggressive lymphoid neoplasm occurring in about
3–7 % of non-Hodgkin lymphomas in the United
States and Europe. Although lymphomas infiltrations
are recognized in about half of post-mortem studies, in
available literature we found only eight cases of
mantle cell lymphoma with renal involvement. Five of
them present MCL related glomerulonephritis, two
show renal MCL infiltration with acute kidney injury
and the last one describes MCL infiltration with acute
tubulo-intrerstitial nephritis. We present the first case
of a patient with the coexistence of renal mantle cell
lymphoma infiltration, subacute membranoprolifera-
tive glomerulonephritis and acute kidney injury.
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Case report
Patient B.C., age 59, was admitted to the Clinic of
Nephrology in August 2011 with a suspected rapidly
progressing glomerulonephritis. In an interview, the
patient described the existence of eczema present for
about 5 years, on face, chest, back and limbs recog-
nized as rosacea-like dermatitis. So far performed
diagnostics has found markers of eosinophilia increas-
ing since 2008 (0.55–2.42 g/l) and neck lymphade-
nopathy (lymph nodes up to 8 9 25 mm) without
further diagnostics. In 2008, the patient was tempo-
rarily treated orally with methylprednisolone and
cetirizine. Additional diagnostics performed in June
2010, during another stay at the Clinic of Dermatol-
ogy, discovered high concentration of total IgE
(20.44 g/l), slight impairment of renal function (cre-
atinine 106.08 lmol/l, GFR-MDRD 67 ml/min/
1.73 m2) with proteinuria (0.5 g/l) and hematuria
(16–25/high-power field) suggesting glomerulone-
phritis, hypercholesterolemia (6.7 mmol/l), hyperbil-
irubinemia (32.8 lmol/l) and elevated erythrocyte
sedimentation rate (28 mm/h). In May 2011, hemor-
rhagic, Henoch–Scho¨nlein-like purpura of hands, feet
and legs joined the existing eczema. For this reason, in
July 2011 the patient was hospitalized in the Clinic of
Infectious Diseases and Allergology, where persistent
features of glomerulonephritis with proteinuria
0.45 g/24 h, elevated levels of sIgA (8.37 g/l), and
proper kidney function (creatinine 79.56 lmol/l,
GFR-MDRD 92 ml/min/1.73 m2) were confirmed. A
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chest radiograph indicated a widened shadow of the
right mediastinum. An ultrasound examination visu-
alized numerous enlarged peripheral lymph nodes in
the neck (up to 13 9 37 mm), enlarged spleen, and
stones of 5–9 mm in both kidneys. A biopsy of the skin
revealed erythema elevatum with neutrophilic, eosin-
ophilic and lymphocytic infiltration around vessels. As
a complication of the biopsy, erysipelas of the left
upper limb occurred (August 2011), with a fever up to
39 C, treated successfully with the second- and third-
generation cephalosporins and metronidazole. During
the treatment, progressive deterioration of renal func-
tion was found. At the admission to the Clinic of
Nephrology, the patient did not report any essential
ailments. Additional diagnostics revealed signs of
progressive multi-organ failure: kidney with nephrotic
syndrome (creatinine 772.92 lmol/l, GFR-MDRD
7 ml/min/1.73 m2; urea 27.89 mmol/l; albumin 25 g/l;
proteinuria 6.88 g/24 h with preserved diuresis
2.5 l/24 h), liver (bilirubin 131.67 lmol/l, GGTP
2,938 U/l; AST 119 U/l, ALT185 U/l), and hemato-
poietic system (Hgb 77 g/l) with the complement
system activation (C3 0.23 g/l; C4 0.01 g/l). The
presence of ANA, p- and c-ANCA antibodies was
not confirmed, but the level of dsDNA antibodies was
elevated up to 44 IU/ml. Ultrasound abdomen exam-
ination showed enlargement of the kidneys (left
kidney length 141 mm, right kidney 134 mm) with
signs of the parenchyma swelling and bilateral kidney
stones. Therefore, it was decided to initiate temporary
renal replacement therapy by hemodialysis every
second day, using a central venous catheter. At the
same time, between hemodialysis, immunosuppres-
sive therapy with i.v. infusions of 3 9 1.0 g methyl-
prednisolone was started. The treatment continued
with oral administration of 60 mg prednisone daily.
The red blood cell concentrate was transfused. After
three hemodialysis interventions, a significant
improvement in renal function was achieved, and
renal replacement therapy was no longer required
(creatinine 114.92 lmol/l, GFR-MDRD 60 ml/min/
1.73 m2, urea 8.3 mmol/l). Moreover, both normali-
zation of liver function (bilirubin 13.68 lmol/l, GGTP
772 U/l, AST 16 U/l, ALT 28 U/l) and correction of
anemia (Hgb 101 g/l) were achieved. A biopsy of the
left kidney and a cervical lymph node was collected
for histopathological evaluation. Based on the pre-
liminary result of the renal biopsy, in which active
lesions were found in the form of vascular loops
necrosis and cellular crescents, intravenous infusion of
1.0 g of cyclophosphamide was administered.
Renal core biopsy submitted for embedding con-
tained 10 glomeruli and cortex parenchyma. On
histological examination, several foci of dense lym-
phocytic infiltration were found. These foci concen-
trated mainly around glomeruli and consisted of
medium-sized slightly atypic lymphocytes with sparse
cytoplasm. The nuclei were of similar size and
cytological features and stayed in close intimacy with
each other without overt molding (Fig. 1). Immuno-
histochemical studies revealed expression of CD20,
CD5 and cyclin D1 markers, while CD3 staining was
Fig. 1 Mantle cell lymphoma infiltration in renal cortex (HE, a 9100, b 9200)
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positive only in non-neoplastic cells (Figs. 2, 3). The
Ki-67 staining displayed a low mitotic activity with
the expression in about 20 % nuclei (Fig. 4). These
morphology and immunoprofile justified the diagno-
sis of mantle cell lymphoma invading renal paren-
chyma. In addition, the biopsy showed features of
membranoproliferative glomerulonephritis including
mesangial proliferation and basal membranes thick-
ening and double contouring (Fig. 5). Segmental,
cellular crescents were present in 2 of 10 glomeruli as
signs of glomerular sclerosis were present in several
glomeruli. A striking feature of Bowman’s capsule
thickening mainly in glomeruli encircled by lym-
phoma infiltrations was clearly visible. Immunoflu-
orescnece staining showed C3 deposits in the
subendothelial capillary space. In addition, only
sparse mononuclear inflammatory infiltration was
present within renal parenchyma as well as slight
tubular injury in the form of epithelial cell edema
and degeneration. The cervical lymph node biopsy
Fig. 2 Expression of CD20 (a 9100) and CD3 (b 9100)
Fig. 3 Expression of cyclin D1 (a 9100) and CD5 (b 9200)
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confirmed the diagnosis with the recognition of
mantle cell lymphoma.
The tests performed 3 weeks after leaving the
hospital showed further improvement in renal func-
tion, only small-degree proteinuria with disappearance
of parenchymal edema in ultrasound imaging (left
kidney length 119 mm and right kidney 115 mm).
Significant changes in clinical and biochemical out-
comes 3 weeks after initial therapy are presented in
Table 1. Patient was transferred to the Clinic of
Hematology, in order to continue treatment.
Discussion
Mantle cell lymphoma (MCL) is a rare aggressive
lymphoid neoplasm occurring in about 3–7 % of non-
Hodgkin (NHL) lymphomas in United States and
Europe [1, 2]. Most frequent NHL infiltrating kidneys
are recognized as extranodal cancers of marginal zone,
especially MALT (mucose-associated lymphoid tissue
lymphoma), DLBCL (diffuse large B-cell lymphoma)
and Burkitt’s lymphomas [10]. Seizure of the genito-
urinary tract by lymphoma occurs rarely, its incidence
is estimated in about 5 %, in which renal involvement
is most common and occurs in approximately 37 % of
cases. On the basis of retrospective studies, Da’as et al.
[3] found that NHL were a rare cause of acute renal
Fig. 4 Expression of Ki-67 in about 20 % of nuclei (9100)
Fig. 5 Double contouring of basal membranes and segmental
sclerosis of glomerulus (9400)
Table 1 Significant changes in clinical and biochemical out-
comes 3 weeks after initial therapy
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failure (9.5 %). Ultrasonographic findings are
expressed as kidneys enlargement with a decreased
echogenicity of the parenchyma.
Glomerulonephritis (GN), in the course of NHL is
one of the causes of acute kidney injury (AKI). In most
cases, membranoproliferative GN, mesangial prolif-
erative GN, crescenic GN or minimal change GN, as
well as membranous GN and IgA nephropathy are
recognized, and clinically expressed as nephrotic
syndrome with microhematuria, seldom with reduced
complement components or cryoglobulinemia [3].
Start of chemotherapy, resulting in partial remission of
NHL, correlates with the decrease in the signs of GN
and improved organ function [3, 4, 9]. Infiltration of
renal parenchyma by lymphoma cells is very rare and
is rated in about 1 % of cases [3]. Most often, renal
lymphoid infiltration is asymptomatic, but sometimes
it can be a cause of acute tubulo-interstitial nephritis.
Start of immunosuppressive treatment with a few
0.5–1.0 g intravenous doses of methylprednisolone
administered every 1–2 days, then continued with oral
prednisone, enables rapid improvement of renal
function, although temporal renal replacement therapy
is at times necessary [6, 7]. So far, eight cases of
kidney impairment due to MCL have been described:
four of them presenting proliferative GN, one focal
segmental glomerulosclerosis (FSGS), two renal MCL
infiltration with AKI, and the last AKI due to acute
tubulo-interstitial nephritis [3–9]. The presented case
is the first announcement describing the coexistence of
renal infiltration by MCL with secondary membrano-
proliferative subacute GN and AKI. There is no clear
explanation of the cause of the patient’s AKI. Renal
failure occurred in the period of acute dermatitis and
suggests diagnosis of post-infectious GN. Whereas
participation of skin infection in the development of
AKI may be important, the existence of chronic GN (at
least from 2008) recognized in the interview seems to
be more essential. The changes discovered in the renal
biopsy showed a secondary GN with an indication of
neoplastic process as the cause of the disease. On the
other hand, untreated infiltration of the kidney with
MCL could be the reason for their tubulo-interstitial
inflammation and AKI [7]. Although renal biopsy
showed only sparse mononuclear inflammatory infil-
tration within renal parenchyma and slight tubular
injury, the examination took place 10 days after
starting intravenous methylprednisolone and already
achieved the returning of renal function (creatinine
97.24 lmol/l). Also, an improvement in renal function
after infusions of methylprednisolone does not indi-
cate clearly the cause of AKI with preserved diuresis.
Such treatment is recommended as a part of the
induction in rapidly progressing GN, acute glomerul-
opathies, as well as acute tubulo-interstitial renal
inflammations. In the presented case, renal biopsy was
performed after the improvement of renal function in
order to determine diagnosis and further treatment.
The diagnosis of MCL renal involvement and neo-
plastic generalization confirmed later in a lymph node
biopsy has become the reason for systemic chemo-
therapy in the Clinic of Hematology.
Summary
The presented case demonstrates for the first time the
possibility of renal infiltration by MCL concomitant
with secondary membranoproliferative GN. It also
shows the importance of the renal biopsy as a useful
diagnostic tool in case of kidney impairment due to the
lymphoma.
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